|
|
||||||||

*
Department of Allergology, Institute of Medical Science, University of Tokyo, Tokyo, Japan; and
Department of Morphogenesis, Institute of Molecular Embryology and Genetics, Kumamoto University School of Medicine, Kumamoto, Japan
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
, and TNF-
to mediate
cell-mediated immune responses such as delayed-type hypersensitivity,
whereas Th2 cells mediate Ab production of B cells by secreting IL-4,
IL-5, and IL-6 (2). Th cell subset differentiation has
been well documented to be determined by cytokines in the environment,
such as IL-4 and IL-12, during the primary Ag response of naive T cells
(3). IL-12 secreted by APC such as macrophages and
dendritic cells promotes the differentiation of naive T cells into Th1
cells (4, 5), while IL-4 produced by naive
CD4+ T cells (6) and NK T cells
(7) promotes the differentiation into Th2 cells. In
addition to the cytokine environment, other mechanisms, such as type of
APC, Ag dose, costimulation, and genetic background, can also be
involved in the differentiation of naive CD4+ T
cells into Th1 and Th2 cells (2, 8, 9). It is generally accepted that nonreceptor-type protein tyrosine kinases (PTKs),4 such as Fyn, Lck, and ZAP-70, are involved in the TCR-mediated early activation signal transduction pathway in T cells (10). In our previous studies PTKs such as Fyn and ZAP-70 were not activated in Th2 clones by anti-CD3 stimulation in contrast to the activation of these molecules in Th1 clones, and herbimycin A treatment inhibited the elevation of the intracellular free Ca2+ concentration in Th1 clones, but not in Th2 clones. Moreover, the amounts of Fyn protein in Th2 clones were approximately one-third to one-fifth of those in Th1 clones (11). Taken together, these results indicate that the activation of these PTKs is not essential for the activation of Th2 clones and suggest a possibility that the impairment in the activation of PTKs results from a decrease in Fyn protein expression in Th2 clones. These results led us to examine the differentiation of naive CD4+ T cells into Th2 cells in fyn-/- mice. We analyzed the cytokine production and differentiation of naive CD4+ T cells from fyn-/- mice compared with those of cells from wild-type mice. Our results show that fyn-/- naive CD4+ T cells efficiently produced Th2 cytokines and polarized toward the Th2 subset even in the absence of exogenous IL-4 and IL-13 in cultures. However, wild-type T cells produced only Th1 cytokines upon priming and polarized toward both Th1 and Th2 subsets. The synthesis of Fyn protein was decreased at the transcriptional level in wild-type CD4+ T cells during the polarization toward Th2 cells by the repetitive stimulation with anti-CD3 plus anti-CD28. These results suggest that Fyn mediates the inhibitory signal(s) against the production of Th2 cytokines and down-regulates the differentiation of naive CD4+ T cells into Th2 subset.
| Materials and Methods |
|---|
|
|
|---|
Fyn-/- mice, described previously (12, 13), were backcrossed 10 times onto the C57BL/6 background and housed in an environmentally controlled clean room at the animal breeding unit of our institute. IL-4-/- mice on the C57BL/6 background and fyn-/- (129S x C57BL/6)F2 hybrid mice were purchased from The Jackson Laboratory (Bar Harbor, ME). fyn-/--IL-4-/- mice were generated by crossing fyn-/- with IL-4-/- mice in the clean room at the animal breeding unit of our institute. They grew to adults normally. C57BL/6 mice were purchased from Japan SLC (Hamamatsu, Japan).
Antibodies
Hybridoma 145-2C11 (anti-CD3
-chain, hamster IgG)
(14) was provided by Dr. J. A. Bluestone (National
Institutes of Health, Bethesda, MD). The mAb was purified from ascites
on a protein A column. Anti-human p59fyn
(anti-Fyn; Fyn301, mouse IgG1) cross-reactive to mouse Fyn was
purchased from Wako Pure Chemical Industries (Osaka, Japan). Purified
anti-CD28 (PV-1, hamster IgG) (15) was provided by Dr.
R. Abe (Research Institute for Biological Sciences, Science University
of Tokyo, Chiba, Japan). Purified anti-human
p56lck (anti-Lck; MOL 171, mouse IgG1)
(16) cross-reactive to mouse Lck was provided by Drs. Y.
Koga and K. Nakamura (Medical Institute of Bioregulation, Kyushu
University, Fukuoka, Japan). Anti-Thy1.2 (HO-13.4, mouse IgM)
(17) was used in the form of ascites. Anti-IL-4 (11B11,
rat IgG1) (18), anti-B7-2 (GL-1, rat IgG2a)
(19), anti-CD8 (53.6.72, rat IgG2a) (20),
and anti-MHC class II (M5/114, rat IgG2b) (21) were
purified from ascites on a protein G column. Anti-heat-stable Ag
(M1/69, rat IgG2a) (22) and anti-Fc
R (2.4G2, rat
IgG2b) (23) were used in the form of culture supernatants.
Anti-B7-1 (1G10, rat IgG2a), FITC-anti-CD44 (KM201, rat IgG2a), and
rabbit antiserum reactive to human and mouse Lck were purchased from
PharMingen (San Diego, CA). Anti-IL-13 (38213.11, rat IgG2b) was
purchased from R&D Systems (Minneapolis, MN).
Preparation of naive CD4+ T cells
T cells were purified by passing spleen cells through nylon wool
and Sephadex G-10 columns. The cells were incubated with a mixture of
anti-CD8, anti-heat-stable Ag, anti-MHC class II, and
anti-Fc
R and were treated with anti-rat IgG Microbeads
(Miltenyi Biotec, Bergisch Gladbach, Germany), followed by passage
through a MACS column according to the manufacturers instruction to
enrich CD4+ T cells. The preparations contained
>90% CD4+ cells, and CD8+
cells were undetectable in a flow cytometric analysis.
CD44low T cells were purified from the
CD4+ T cells by sorting in a FACStar (BD
Biosciences, Mountain View, CA) after staining with FITC-anti-CD44.
The purities of the
CD4+CD44lowCD45RBhigh
population in CD44low T cells were confirmed flow
cytometrically to be >96% and were used as naive
CD4+ T cells. We confirmed in preliminary
experiments that there was no significant difference between
fyn-/- and wild-type naive
CD4+ T cells in terms of TCR and CD3 expression
in flow cytometry.
Preparation of T cell-depleted spleen accessory cells
Spleen cells from wild-type mice were depleted of T cells by the
treatment with anti-Thy1.2 and 1-wk-old rabbit complement.
TCR
+ cells remaining in the preparations
were confirmed to be <5% by flow cytometry. The preparation was used
as accessory cells after irradiation with 40 Gy.
In vitro priming of naive CD4+ T cells
Naive CD4+ T cells (1 x 106 cells/culture) were primed for 5 days with soluble anti-CD3 in the presence of accessory cells or with plate-coated anti-CD3 in the presence of soluble anti-CD28 in a flat-bottom 24-well microplate without the addition of any exogenous cytokine. Viable T cells were recovered by Ficoll-Hypaque centrifugation and used as once-primed T cells. The once-primed T cells were reprimed for 5 days under the same conditions as those used for the first priming, and viable T cells were recovered on Ficoll-Hypaque and used as twice-primed T cells. In some experiments, fyn-/- naive CD4+ T cells were primed in the presence of 10 ng/ml of rIL-12 (provided by Genetics Institute, Cambridge, MA).
In vitro stimulation of T cells
For the assessment of cytokine production, naive, once-primed,
or twice-primed CD4+ T cells (1 x
105 cells/culture) were stimulated with soluble
anti-CD3 in the presence of accessory cells (5 x
105 cells/culture) in a flat-bottom 96-well
microplate, and the culture supernatants were assayed for IL-2, IL-4,
IL-5, and IFN-
. For the assessment of Fyn and Lck activities, the
naive, once-primed, or twice-primed CD4+ T cells
(1 x 106 cells/100 µl/culture) from
fyn-/- and wild-type mice were added to
the wells of 24-well flat-bottom plate and incubated at 37°C for 5
min, followed by the addition of T cell-depleted spleen accessory cells
(5 x 106 cells/100 µl/culture) incubated
with 10 µg/ml anti-CD3 for 15 min at 4°C, and then warmed at
37°C for 5 min. The plate was immediately centrifuged at 200 x
g for 30 s at room temperature, and then incubated at
37°C for 0, 5, 15, and 30 min.
Assay for cytokines
IL-2, IL-4, IL-5, and IFN-
in culture supernatants were
assayed by ELISA. All the mAbs specific for mouse IL-2, IL-4, IL-5, and
IFN-
used for capture and detection of cytokines were purchased from
PharMingen. ELISA was performed following the instruction of
PharMingen. The detection limits for IL-2, IL-4, IL-5, and IFN-
were
25, 10, 5, and 150 pg/ml, respectively. The results are presented as
the average of duplicate assays.
Immunoprecipitation
CD4+ T cells, naive, once-primed, or twice-primed, were solubilized in 1 ml cold TNE buffer consisting of 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1% (v/v) Nonidet P-40 containing 20 mM EDTA, 10 µg/ml aprotinin, 0.4 mM sodium vanadate, and 10 mM sodium pyrophosphate. The cell lysates were centrifuged at 10,000 x g for 5 min, and the supernatants were precleared with protein G-Sepharose. The lysates were then incubated with 1 µg anti-Fyn or anti-Lck at 4°C for 1 h, and the immune complexes were precipitated with protein G-Sepharose.
Immune complex kinase assay and immunoblotting
The immune complexes precipitated with protein G-Sepharose were
washed four times with TNE buffer and then four times with kinase
buffer (50 mM HEPES-NaOH (pH 7.4), 20 mM MnCl2,
and 10 mM MgCl2). The immunoprecipitates were
suspended in 10 µl of the kinase buffer containing 10 µCi
[
-32P]ATP and incubated at 30°C for 30 min
with continuous mixing in the presence of 1 µg denatured enolase for
the assessment of kinase activity for an exogenous substrate. The
reaction was stopped by the addition of 10 µl of 3x sample buffer
(195 mM Tris-HCl (pH 6.8), 9% SDS, 15% 2-ME, and 30% glycerol). The
mixture was then boiled for 3 min, subjected to SDS-PAGE under reducing
conditions, and then transferred to polyvinylidene difluoride
microporous membrane (Immobilon PVDF; Millipore, Bedford, MA), followed
by autoradiography for the detection of kinase activity. To analyze Fyn
and Lck protein expression, the membrane was blocked in 5%
BSA/Tris-buffered saline (20 mM Tris-HCl (pH 7.5) and 150 mM NaCl) and
then incubated with anti-Fyn or rabbit antiserum reactive to human
and mouse Lck. Immunoblots were incubated with appropriate biotinylated
Ab, anti-mouse Ig (Amersham Pharmacia Biotech, Little Chalfont,
U.K.), and anti-rabbit Ig (Amersham Pharmacia Biotech), and then
incubated with streptavidin-alkaline phosphatase (Amersham Pharmacia
Biotech). After the incubation the membrane was washed with TBS
containing 0.1% Tween 20, and developed with nitroblue tetrazolium and
5-bromo-4-chloro-3-indolyl phosphate.
Detection of mRNA for fyn
To analyze the accumulation of mRNA for fyn, total RNA was isolated from CD4+ T cells using the acid guanidinium-phenol-chloroform method (24), and Northern blot analysis was conducted using a 0.7-kb BglI-HincII fragment of cDNA probe for fyn, pSN-2 (provided by Dr. T. Yamamoto, Department of Oncology of our institute) (25). The signal intensities were quantified by densitometry using an image analyzer BAS-2000II (Fuji Photo Film, Tokyo, Japan).
| Results |
|---|
|
|
|---|
To evaluate the role of Fyn in cytokine production of naive
CD4+ T cells, naive CD4+ T
cells from fyn-/- mice were stimulated
with soluble anti-CD3 in the presence of T cell-depleted spleen
cells from wild-type mice as accessory cells, and the culture
supernatants were assayed for cytokines. The
fyn-/- naive CD4+
T cells produced comparable or even greater amounts of IL-2 compared
with those produced by the cells from wild-type mice after stimulation
with 0.110 µg/ml anti-CD3. In addition,
fyn-/- naive CD4+
T cells produced typical Th2 cytokines, IL-4 and IL-5, in response to 1
µg/ml (data not shown) and 10 µg/ml (Fig. 1
) anti-CD3. The wild-type T cells
produced neither IL-4 nor IL-5 for at least 120 h upon stimulation
with 0.0110 µg/ml anti-CD3 (data not shown). Naive
CD4+ T cells from neither
fyn-/- nor wild-type mice produced any
cytokine examined by the stimulation with soluble anti-CD3 in the
absence of accessory cells (data not shown). It is possible that the
above results could be obtained only in T cells from C57BL/6 background
mice. Therefore, we examined the cytokine production of naive
CD4+ T cells from both
fyn-/- and wild-type (129S x
C57BL/6)F2 hybrid mice, and essentially the same results
were obtained (data not shown). Thus,
fyn-/- naive CD4+
T cells are shown to efficiently produce Th2 cytokines.
|
In the above experiment we used T cell-depleted spleen cells as
accessory cells. Therefore, it is possible that the costimulation with
accessory cells plays an important role in the Th2 cytokine production
of fyn-/- naive
CD4+ T cells. Therefore, we examined the effects
of anti-B7-1 and anti-B7-2 on their cytokine production
stimulated with soluble anti-CD3 in the presence of accessory
cells. In the presence of anti-B7-2, IL-2 production of
fyn-/- T cells was remarkably reduced
compared with that of wild-type T cells, and their IL-4 and IL-5
production was abrogated (Fig. 2
). The
inclusion of anti-B7-1 also suppressed the production of both IL-4
and IL-5 by fyn-/- T cells, although
IL-2 production was not affected. The production of IL-4 and IL-5 by
fyn-/- T cells was confirmed to be
suppressed by anti-B7-1 or anti-B7-2 for 24120 h after the
stimulation with anti-CD3 (data not shown).
|
, after stimulation
with anti-CD3 plus anti-CD28, while wild-type T cells produced
IL-2 and IFN-
, but not detectable levels of IL-4 and IL-5, after
stimulation (Fig. 3
, but not IL-4 and IL-5, whereas
fyn-/- T cells produced no cytokines by
the stimulation (Fig. 3
|
Taken together, these results suggest that the costimulation signal through CD28 plays a critical role in inducing Th2 cytokine production of fyn-/- naive CD4+ T cells stimulated with anti-CD3.
Role of Fyn in the polarization of naive CD4+ T cells toward the Th2 subset
To examine the role of Fyn in the differentiation of naive
CD4+ T cells into the Th2 subset, we primed
fyn-/- naive CD4+
T cells with plate-coated anti-CD3 plus soluble anti-CD28. Five
days after the priming, they were stimulated with anti-CD3 on
accessory cells, and the culture supernatants were assayed for
cytokines (Fig. 4
). The
fyn-/- T cells produced only Th2
cytokines after stimulation, indicating that
fyn-/- naive CD4+
T cells were polarized toward the Th2 subset by the priming. In
contrast, wild-type T cells primed in the same protocol produced both
Th1 and Th2 cytokines after stimulation. Similar experiments were
conducted by priming of wild-type CD4+ T cells
with soluble anti-CD3 in the presence of accessory cells without
addition of any exogenous cytokine or by using
fyn-/- naive CD4+
T cells from (129S x C57BL/6)F2 hybrid
mice. Essentially the same results as those described above were
obtained (data not shown).
|
even though fyn-/-
naive CD4+ T cells differentiated into Th1 cells.
Therefore, we examined whether the
fyn-/- T cells could produce IFN-
.
When the fyn-/- naive
CD4+ T cells were primed with plate-coated
anti-CD3 plus soluble anti-CD28 in the presence of 10 ng/ml
rIL-12 and 10 µg/ml anti-IL-4, they (1 x
105 cells) produced 9.7 ng/ml IFN-
upon
stimulation with 10 µg/ml anti-CD3 on accessory cells, indicating
that fyn-/- T cells retain the ability
to produce IFN-
and also to differentiate into the Th1 subset.
It is also possible that fyn-/- Th1
cells are more susceptible to activation-induced cell death (AICD) than
wild-type Th1 cells. Therefore, we compared the
fyn-/- and wild-type T cells primed with
plate-coated anti-CD3 plus soluble anti-CD28 in terms of
susceptibility to AICD. The AICD was assayed by flow cytometry using
FITC-annexin V. We observed no difference in the susceptibility to AICD
between the fyn-/- and wild-type T
cells. The percentages of cells positively stained with annexin V were
27.4 and 23.9% in fyn-/- and wild-type
T cells, respectively, within 24 h after restimulation with
anti-CD3 on accessory cells. We used whole
CD4+ T cells for the above assay, because
IFN-
-producing T cells could not be detected in the
fyn-/- T cells in our system by
intracellular staining (data not shown). Therefore, it is unlikely that
the fyn-/- Th1 cells are more
susceptible to AICD than wild-type Th1 cells.
It is well documented that exposure to IL-4 drives naive
CD4+ T cells to the Th2 subset in the initial
immune response (3, 26). In the above experiment
fyn-/- naive CD4+
T cells produced a large amount of IL-4 during priming, suggesting that
fyn-/- T cells differentiated into Th2
cells in an environment with a large amount of autocrine
IL-4. To examine this possibility, we generated
fyn-/--IL-4-/-
mice by crossing fyn-/- with
IL-4-/- mice, and
fyn-/--IL-4-/-
naive CD4+ T cells were primed with plate-coated
anti-CD3 plus soluble anti-CD28. Five days after the priming,
they were stimulated with anti-CD3 on accessory cells, and the
culture supernatants were assayed for IL-5 and IFN-
(Fig. 5
). The
fyn-/--IL-4-/- T
cells produced both IL-5 and IFN-
, while
IL-4-/- T cells produced IFN-
, but
little IL-5 (Fig. 5
), indicating that
fyn-/- naive CD4+
T cells could polarize toward Th2 cells even in the absence of IL-4.
These results were confirmed by intracellular staining for these
cytokines (data not shown).
|
Role of Lck in the cytokine production and polarization of naive CD4+ T cells toward the Th2 subset
Activation of Lck kinase has been reported to be an important
signal for the differentiation of Ag-stimulated naive
CD4+ T cells into the Th2 subset
(28). Therefore, we examined Lck kinase activity in
fyn-/- T cells stimulated with
anti-CD3 on accessory cells compared with that in wild-type T cells
by immune complex kinase assay. As shown in Fig. 6
A, Lck kinase activity was
not increased in naive CD4+ T cells from either
fyn-/- or wild-type mice by the
stimulation in terms of either enolase phosphorylation or
autophosphorylation, suggesting that the activation of Lck is not
necessarily required for the polarization toward the Th2 subset in our
system. In the T cells primed with plate-coated anti-CD3 plus
soluble anti-CD28, Lck kinase activity in wild-type T cells was
significantly increased 5 min after the stimulation with anti-CD3
on accessory cells and decreased thereafter; however, in
fyn-/- T cells the activity was not
increased (Fig. 6
B). No apparent difference was observed
between the fyn-/- and wild-type T cells
in the amount of Lck immunoprecipitated from 5 x
106 naive or primed T cells (Fig. 6
). Taken
together, these results suggest that Lck activity does not play a
critical role in signaling for Th2 cytokine production, at least in our
system.
|
We next examined whether the priming of wild-type naive
CD4+ T cells with the costimulation of
anti-CD3 and anti-CD28 decreases the activity and expression of
Fyn kinase. When naive T cells were primed with two cycles of
costimulation with anti-CD3 and anti-CD28, they produced IL-4,
but little IFN-
, upon stimulation with anti-CD3 on accessory
cells (Fig. 7
A); that is,
naive CD4+ T cells polarized toward the Th2
subset by the two cycles of the priming as previously shown
(29). Then, aliquots of T cells primed once or twice under
the same conditions as described above were assayed for Fyn kinase
activity by immune complex kinase assay after the stimulation with
anti-CD3 on accessory cells. The kinase activity peaked 515 min
after the stimulation in terms of autophosphorylation and also of
enolase phosphorylation in naive and once-primed T cells. However, no
Fyn activity was detected for 30 min in the twice-primed T cells; that
is, no autophosphorylation band was detected for 30 min, and the
phosphorylation of enolase was not increased by the stimulation (Fig. 7
B). In our stimulation procedure it is difficult to define
time zero. Therefore, we also examined the Fyn activity in twice-primed
T cells 60 min after the stimulation, and no activity of Fyn was
confirmed (data not shown).
|
1/10th that in naive T cells (Fig. 8
|
| Discussion |
|---|
|
|
|---|
1 and promote the differentiation of Th1 subset from naive
CD4+ T cells, while the peptides that weakly bind
to TCR did not induce the activation of either ZAP-70 or phospholipase
C-
1 and promoted Th2 subset differentiation (31). The
activation of ZAP-70 and phospholipase C-
1 was not induced in
fyn-/- naive CD4+
T cells by stimulation with either anti-CD3 on accessory cells or
anti-CD3 plus anti-CD28 (data not shown). These results
indicate that activation of these PTKs such as Fyn and ZAP-70 is not
necessary for differentiation of naive T cells into the Th2 subset.
Collectively, these results suggest that the activation of these PTKs
inhibits the differentiation of naive CD4+ T
cells into Th2 cells. The fyn-/- naive CD4+ T cells produced a large amount of IL-4 after stimulation with anti-CD3 plus anti-CD28. It is well documented that IL-4 promotes Th2 subset differentiation (3). Therefore, it is possible that fyn-/- naive CD4+ T cells were polarized toward the Th2 subset by exposure to a high concentration of autocrine IL-4. However, fyn-/--IL-4-/- naive T cells could also polarize toward the Th2 subset even in the absence of exogenous IL-4 in cultures. These results suggest that Th2 subset differentiation of fyn-/- naive T cells could be induced by an IL-4-independent mechanism. Consistent with our results, human naive CD4+ T cells were reported to differentiate into Th2 cells in the presence of neutralizing anti-IL-4 after priming with anti-CD3 plus anti-CD28 (32). T cells from IL-4-/- mice infected with Leishmania major were also shown to produce Th2 cytokines by Ag restimulation in vitro (33).
In our results the fyn-/- naive CD4+ T cells were polarized toward the Th2 subset, but wild-type T cells were polarized toward both Th1 and Th2 subsets after the priming. It has been demonstrated that Th1 cells were more susceptible than Th2 cells to AICD (34). However, there was no difference in the susceptibility to AICD between the fyn-/- and wild-type T cells in our system. Therefore, it is unlikely that fyn-/- CD4+ T cells were easily polarized toward the Th2 subset because Th1-polarizing cells in fyn-/- mice are more susceptible to AICD than those in wild-type mice.
Our results showed that wild-type T cells polarized toward the Th2
subset concomitant with the reduction in Fyn protein expression, and
Fyn kinase activity was not detected in the cells that produced
Th2 cytokines after anti-CD3 stimulation. These results are
consistent with our previous findings that Th2 clones expressed a low
level of Fyn protein (approximately one-fourth to one-sixth of Th1
clones) and the Fyn kinase activities in those clones were not
detectable after TCR stimulation (11). Fc
receptor-nonbinding anti-CD3 induced IL-4 production of Th2 clones
without phosphorylation of TCR-
, ZAP-70, or mitogen-activated
protein kinase, although it stimulated IL-2 production of Th1 clones
with low efficiency (35). Taken together, these results
indicate that the activation of PTKs such as Fyn and ZAP-70 is not
required for the production of Th2 cytokines. The most important
finding in our present experiments may be the reduction of Fyn protein
expression in T cells during polarization toward the Th2 subset. Recent
studies showed that stimulation with only TCR cross-linking induced the
differentiation of naive CD4+ T cells into Th1
cells, but not Th2 cells, while costimulation with anti-CD28 was
shown to induce differentiation into Th2 cells by accelerating the
sensitivity of naive CD4+ T cells to IL-4
(36). Therefore, it is possible that CD28 mediates the
signal(s) for reduction of Fyn protein expression. Costimulation with
anti-CD28 induced IL-4 production in naive
CD4+ T cells (32), and it was shown
to be essential for the differentiation of naive
CD4+ T cells to the Th2 subset (37).
The requirement for IL-4R-mediated signal for the differentiation of
naive CD4+ T cells into Th2 cells has been
demonstrated by targeted disruption of the IL-4 and STAT6 genes
(38, 39, 40). Therefore, it is also possible that IL-4R
mediates the signal(s) to reduce Fyn protein expression. Indeed,
treatment with anti-IL-4 inhibited the reduction of Fyn protein
expression in wild-type T cells induced by priming with anti-CD3
plus anti-CD28 (data not shown).
In summary, our results suggest that the following mechanisms may be operative in the differentiation of naive CD4+ T cells to the Th2 subset. CD3 plus CD28 signals directly or indirectly down-regulate the expression of Fyn protein and enhance IL-4 production, resulting in the differentiation of naive CD4+ T cells into the Th2 subset.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Toshiki Tamura, Department of Allergology, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan. E-mail address: toshikit{at}ims.u-tokyo.ac.jp ![]()
3 Present address: Ogata Institute for Medical and Chemical Research, Inc., Chiyoda-ku, Tokyo 101-0031, Japan. ![]()
4 Abbreviations used in this paper: PTK, protein tyrosine kinase; AICD, activation-induced cell death; anti-Fyn, anti-human p59fyn; anti-Lck, anti-human p56lck. ![]()
Received for publication July 17, 2000. Accepted for publication May 31, 2001.
| References |
|---|
|
|
|---|
production and diminishes interleukin 4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90:10188.This article has been cited by other articles:
![]() |
B. Gomes, M. Savignac, M. D. Cabral, P. Paulet, M. Moreau, C. Leclerc, R. Feil, F. Hofmann, J.-C. Guery, G. Dietrich, et al. The cGMP/Protein Kinase G Pathway Contributes to Dihydropyridine-sensitive Calcium Response and Cytokine Production in TH2 Lymphocytes J. Biol. Chem., May 5, 2006; 281(18): 12421 - 12427. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shibuya, J. Shirakawa, T. Kameyama, S.-i. Honda, S. Tahara-Hanaoka, A. Miyamoto, M. Onodera, T. Sumida, H. Nakauchi, H. Miyoshi, et al. CD226 (DNAM-1) Is Involved in Lymphocyte Function-associated Antigen 1 Costimulatory Signal for Naive T Cell Differentiation and Proliferation J. Exp. Med., December 15, 2003; 198(12): 1829 - 1839. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Stephensen, R. Rasooly, X. Jiang, M. A. Ceddia, C. T. Weaver, R. A. S. Chandraratna, and R. P. Bucy Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway J. Immunol., May 1, 2002; 168(9): 4495 - 4503. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |